Idorsia Ltd
Idorsia Ltd
Community score
moreIdorsia Ltd is a biopharmaceutical company incorporated on October 2, 2017. The headquarters of Idorsia is situated in Allschwil, Switzerland. The company primarily engages in the discovery, development, and commercialization of small molecules for the treatment of diseases with significant unmet medical needs in the biopharmaceutical sector. At the current stage of its business, Idorsia is in the process of late-stage clinical development for its most advanced candidates, focusing on potential future brands that may be approved and marketed. The company's efforts are geared toward achieving regulatory approvals in various regions, which would include key pharmaceutical markets that could potentially involve the United States, European countries, and other regions contingent on successful clinical trial outcomes and the subsequent green light from regulatory bodies. (Powered by AI)
Around 2 billion (Bn) people worldwide lack access to essential medications1;p1. At least 10% of the household budget of over 800 million (Mn) people goes into healthcare expenditure, and 100 Mn people are pushed to extreme poverty due to unafford...
In order to ensure strong institutions and the well-being of society, governments spend a considerable amount of the state's budget on public goods and services, which are funded by taxes paid by individuals and corporations1. Corporate taxes acco...
The pharmaceutical industry plays a key role in disease eradication by researching and developing novel cures and treatment options, helping patients to live longer, healthier lives1. According to the WHO, 2 billion (Bn) people lack access to esse...